Heparin Sod 10,000u/ml Inj, 5ml
Overview
What is this medicine?
How to Use This Medicine
To ensure safe and effective use, take this medication exactly as directed by your doctor. Carefully read all the information provided to you and follow the instructions closely. This medication can be administered in various ways, including:
Through a catheter
As an injection into a vein
As an injection into the fatty part of the skin
As an infusion into a vein over a period of time
If you have any questions or concerns, be sure to discuss them with your doctor.
Storing and Disposing of Your Medication
If you need to store this medication at home, consult with your doctor, nurse, or pharmacist for guidance on proper storage.
What to Do If You Miss a Dose
If you miss a dose, contact your doctor immediately to determine the best course of action.
Lifestyle & Tips
- Report any signs of unusual bleeding or bruising immediately to your doctor or nurse.
- Avoid activities that could cause injury or bleeding (e.g., contact sports, using sharp objects carelessly).
- Use a soft toothbrush and an electric razor to minimize bleeding.
- Inform all healthcare providers, including dentists, that you are taking heparin.
- Do not take aspirin, NSAIDs (like ibuprofen or naproxen), or other blood thinners unless specifically instructed by your doctor.
Available Forms & Alternatives
Available Strengths:
- Heparin Lock Flush 100u/ml Inj, 1ml
- Heparin Lock Flush 100u/ml Inj, 5ml
- Heparin Sod 1000u/ml Inj, 2ml
- Heparin Sod 5,000u/ml Inj, 10ml
- Heparin Sod 5000u/0.5ml Inj, 0.5ml
- Heparin Sod 5,000u/ml Inj, 1ml
- Heparin Lock Flush 10u/ml Inj, 5ml
- Heparin Sod 1000u/ml Inj, 10ml
- Heparin Sod 1000u/ml Inj, 1ml
- Heparin Sod 10,000u/ml Inj, 4ml
- Heparin Sod 5000u/ml Carpuject, 1ml
- Heparin Lock Flush 100u/ml Inj, 3ml
- Heparin Sod 1000u/ml Inj, 30ml
- Heparin Sod 5000u/ml Prefilled Syr
- Heparin Sod 5000u/ml Inj, 1ml
- Heparin Lock Flush 10u/ml Inj, 1ml
- Heparin Sod 10,000u/ml Inj, 1ml
- Heparin Sod 20000u/ml Inj 1ml
- Heparin Sod 10,000u/ml Inj, 5ml
- Heparin Lock Flush 10u/ml Inj, 3ml
- Heparin Sod/nacl 25000u Inj, 500ml
- Heparin Sod/d5w 100u/ml Inj, 250ml
- Hep Sod/nacl 25000unt Inj, 250ml
- Heparin Na 50u/1ml/sod Cl 0.45% Inj
- Heparin Posiflush 100u/ml Inj, 3ml
- Heparin Sod 1000u/ml Inj,30ml
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of bleeding, including:
+ Vomiting or coughing up blood
+ Vomit that resembles coffee grounds
+ Blood in the urine
+ Black, red, or tarry stools
+ Bleeding from the gums
+ Abnormal vaginal bleeding
+ Unexplained bruises or bruises that enlarge
+ Uncontrollable bleeding
Neurological symptoms, such as:
+ Weakness on one side of the body
+ Difficulty speaking or thinking
+ Changes in balance
+ Drooping on one side of the face
+ Blurred vision
Feeling confused
Severe headache
Dizziness or fainting
Upset stomach or vomiting
Unusual burning sensations, particularly on the soles of the feet
Swelling, warmth, numbness, color changes, or pain in a leg or arm
Chest pain or pressure
Shortness of breath
Back pain
Groin or pelvic pain or swelling
Changes in skin color at the injection site
Skin breakdown at the site of administration
Fever or chills
Other Possible Side Effects
Like all medications, this drug can cause side effects. However, many people do not experience any side effects or only have mild ones. If you have any side effects that bother you or persist, contact your doctor for advice.
Please note that this list is not exhaustive, and you may experience other side effects not mentioned here. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Any unusual bleeding (e.g., nosebleeds, bleeding gums, blood in urine or stools, heavy menstrual bleeding)
- Excessive bruising or large bruises that appear without injury
- Severe headache or dizziness
- Weakness or numbness on one side of the body
- Sudden, severe pain or swelling in a limb
- Chest pain or shortness of breath
- Any new rash or skin lesions, especially at injection sites
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
If you are allergic to pork products, as this may be relevant to your treatment.
Certain health conditions, including:
+ Bleeding problems or a low platelet count.
+ A history of low platelet count caused by heparin or pentosan polysulfate.
This list is not exhaustive, and it is crucial to discuss all your health problems and medications with your doctor.
To ensure safe treatment, provide your doctor and pharmacist with a comprehensive list of:
All prescription and over-the-counter medications you are taking.
Any natural products or vitamins you are using.
* Your complete medical history, including any health problems.
Before starting, stopping, or changing the dose of any medication, including this one, consult with your doctor to confirm it is safe to do so.
Precautions & Cautions
While on this medication, you may experience easier bleeding, so it's crucial to be cautious and avoid injuries. To minimize the risk of bleeding, use a soft-bristled toothbrush and an electric razor for shaving.
There is a risk of severe and potentially life-threatening bleeding problems associated with this medication. Additionally, this drug can cause a condition known as heparin-induced thrombocytopenia (HIT), which may lead to the formation of blood clots, also referred to as heparin-induced thrombocytopenia and thrombosis (HITTS). Both HIT and HITTS can be fatal or cause other serious complications, and they may occur up to several weeks after stopping the medication. If you have any questions or concerns, discuss them with your doctor. It is also important to undergo blood tests as directed by your doctor and to consult with them regarding any concerns.
This medication may interfere with certain laboratory tests, so it's vital to inform all your healthcare providers and laboratory personnel that you are taking this drug.
If you fall, injure yourself, or hit your head, contact your doctor immediately, even if you feel fine.
Ensure that you have the correct product, as this medication is available in various containers and strengths. If you have any doubts, consult your doctor or pharmacist.
If you are allergic to sulfites, inform your doctor, as some products may contain sulfites.
Individuals over 60 years old should use this medication with caution, as they may be more susceptible to side effects.
Some products contain benzyl alcohol, which can cause serious side effects in newborns and infants, particularly when combined with other medications containing benzyl alcohol. If you are a parent or caregiver, consult your doctor to determine if the product contains benzyl alcohol and to discuss alternative options.
If you are pregnant, planning to become pregnant, or breastfeeding, inform your doctor to discuss the potential benefits and risks of this medication to both you and your baby.
Overdose Information
Overdose Symptoms:
- Excessive bleeding (e.g., nosebleeds, gum bleeding, hematuria, melena, petechiae, ecchymoses)
- Hypotension (low blood pressure)
- Tachycardia (rapid heart rate)
- Shock
What to Do:
Seek immediate medical attention. The antidote for heparin overdose is protamine sulfate, which neutralizes heparin's anticoagulant effect. Call 911 or your local emergency number. For non-emergencies, call Poison Control at 1-800-222-1222.
Drug Interactions
Contraindicated Interactions
- History of Heparin-Induced Thrombocytopenia (HIT)
- Active major bleeding
- Severe thrombocytopenia
- Uncontrolled hypertension
- Recent surgery of the brain, spinal cord, or eye
- Bacterial endocarditis
- Lumbar puncture or regional anesthetic procedures (epidural/spinal anesthesia) in patients receiving therapeutic anticoagulation
Major Interactions
- Other anticoagulants (e.g., warfarin, dabigatran, rivaroxaban, apixaban, edoxaban): Increased risk of bleeding.
- Antiplatelet agents (e.g., aspirin, clopidogrel, ticagrelor, prasugrel): Increased risk of bleeding.
- NSAIDs (e.g., ibuprofen, naproxen, celecoxib): Increased risk of bleeding.
- Thrombolytic agents (e.g., alteplase, tenecteplase): Significantly increased risk of bleeding.
- Dextran: Increased risk of bleeding.
Moderate Interactions
- Corticosteroids (long-term use): May increase risk of bleeding.
- Nitroglycerin (IV): May decrease heparin's anticoagulant effect (monitor aPTT).
- Probenecid: May increase heparin levels.
- Certain herbal supplements (e.g., ginkgo biloba, garlic, ginger, dong quai, feverfew): May increase bleeding risk.
Minor Interactions
- Not many specific minor interactions; most interactions relate to bleeding risk.
Monitoring
Baseline Monitoring
Rationale: To establish baseline platelet count and assess for anemia or other hematologic abnormalities before initiating therapy, and to monitor for thrombocytopenia (including HIT).
Timing: Prior to initiation of therapy
Rationale: To establish baseline coagulation status and for subsequent therapeutic monitoring of heparin.
Timing: Prior to initiation of therapy
Rationale: To establish baseline coagulation status and assess for other coagulopathies.
Timing: Prior to initiation of therapy
Rationale: To assess organ function that may influence drug clearance or bleeding risk.
Timing: Prior to initiation of therapy
Rationale: To assess for baseline gastrointestinal bleeding.
Timing: Prior to initiation of therapy (if clinically indicated)
Routine Monitoring
Frequency: Every 4-6 hours initially for continuous IV infusion until therapeutic range is achieved, then daily or as per protocol. Not typically monitored for SC prophylaxis.
Target: 1.5-2.5 times the control value (or specific institutional therapeutic range, e.g., 60-80 seconds)
Action Threshold: Values outside target range require dose adjustment as per nomogram or protocol.
Frequency: Every 2-3 days during therapy (especially from day 4 to day 14 or until heparin is discontinued) to monitor for Heparin-Induced Thrombocytopenia (HIT).
Target: Normal range (150,000-450,000/ยตL)
Action Threshold: A drop in platelet count by >50% from baseline, or new onset thrombocytopenia (<100,000/ยตL), especially if associated with new thrombosis, should prompt suspicion for HIT and discontinuation of heparin.
Frequency: Daily or as clinically indicated
Target: Normal range
Action Threshold: Significant drop may indicate bleeding.
Frequency: Continuously
Target: Absence of bleeding
Action Threshold: Any signs of bleeding (e.g., hematuria, melena, epistaxis, bruising, petechiae, gum bleeding, severe headache, altered mental status) require immediate assessment and potential intervention.
Symptom Monitoring
- Unusual bleeding or bruising (e.g., nosebleeds, gum bleeding, blood in urine or stool, excessive bruising)
- Petechiae (small red spots on skin)
- Melena (black, tarry stools)
- Hematuria (blood in urine)
- Severe headache or dizziness (may indicate intracranial bleeding)
- Unusual pain or swelling (may indicate internal bleeding)
- Signs of Heparin-Induced Thrombocytopenia (HIT): new or worsening thrombosis (e.g., limb pain, swelling, coolness, discoloration), skin lesions at injection sites, sudden drop in platelet count.
Special Patient Groups
Pregnancy
Heparin does not cross the placenta and is generally considered safe for use during pregnancy when anticoagulation is required. However, it is classified as Pregnancy Category C by the FDA due to animal studies showing some adverse effects at high doses, though human data suggest low risk.
Trimester-Specific Risks:
Lactation
Heparin is considered safe for use during breastfeeding (Lactation Risk Category L1). It is a large molecule and is not excreted into breast milk in clinically significant amounts, and it is not orally absorbed by the infant.
Pediatric Use
Dosing is weight-based and requires careful titration and monitoring of aPTT. Neonates and infants may require higher doses per kg due to higher antithrombin levels and faster clearance. Increased risk of bleeding, especially in very low birth weight infants. Close monitoring for bleeding and HIT is essential.
Geriatric Use
Elderly patients (โฅ65 years) may have an increased risk of bleeding compared to younger adults, even at standard doses. This may be due to age-related changes in renal function, hepatic function, or increased fragility of blood vessels. Close monitoring of aPTT, platelet count, and signs of bleeding is crucial. Lower initial doses or more conservative dosing may be considered.
Clinical Information
Clinical Pearls
- Heparin has a narrow therapeutic window, requiring careful monitoring of aPTT for therapeutic efficacy and safety.
- Heparin-Induced Thrombocytopenia (HIT) is a serious, immune-mediated complication characterized by a significant drop in platelet count (typically >50% from baseline) and a paradoxical increase in thrombotic risk. It usually occurs 5-10 days after heparin initiation. If suspected, discontinue heparin immediately and initiate an alternative non-heparin anticoagulant.
- Protamine sulfate is the specific antidote for heparin overdose, effectively neutralizing its anticoagulant effects.
- Heparin clearance is non-linear and dose-dependent; higher doses lead to disproportionately longer half-lives.
- Subcutaneous heparin is used for prophylaxis, while intravenous heparin is used for therapeutic anticoagulation.
- Heparin is safe in patients with renal impairment, unlike many LMWHs, as its primary clearance is non-renal.
Alternative Therapies
- Low Molecular Weight Heparins (LMWHs) (e.g., enoxaparin, dalteparin): For DVT/PE prophylaxis and treatment, ACS.
- Fondaparinux: For DVT/PE prophylaxis and treatment.
- Direct Oral Anticoagulants (DOACs) (e.g., dabigatran, rivaroxaban, apixaban, edoxaban): For DVT/PE treatment and prevention of recurrence, stroke prevention in atrial fibrillation.
- Warfarin: For long-term anticoagulation.